|
TM6SF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.296000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.678200E-02 |
| Normal-vs-Stage2 |
1.499830E-02 |
| Normal-vs-Stage3 |
2.610000E-01 |
| Normal-vs-Stage4 |
5.112200E-01 |
| Stage1-vs-Stage2 |
4.101800E-02 |
| Stage1-vs-Stage3 |
7.758800E-01 |
| Stage1-vs-Stage4 |
9.462200E-01 |
| Stage2-vs-Stage3 |
3.166400E-01 |
| Stage2-vs-Stage4 |
2.568600E-01 |
| Stage3-vs-Stage4 |
8.355600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.044200E-02 |
| Normal-vs-AfricanAmerican |
5.784100E-03 |
| Normal-vs-Asian |
4.746600E-01 |
| Caucasian-vs-AfricanAmerican |
1.332830E-01 |
| Caucasian-vs-Asian |
8.343800E-01 |
| AfricanAmerican-vs-Asian |
5.069200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.495300E-03 |
| Normal-vs-Female |
6.996400E-02 |
| Male-vs-Female |
5.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.580000E-02 |
| Normal-vs-Extreme_Weight |
2.678400E-02 |
| Normal-vs-Obese |
2.718500E-02 |
| Normal-vs-Extreme_Obese |
7.397800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.290000E-01 |
| Normal_Weight-vs-Obese |
8.531600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.212200E-01 |
| Extreme_Weight-vs-Obese |
8.627000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.675000E-01 |
| Obese-vs-Extreme_Obese |
4.246200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.212200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.761800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.445600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.129800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.443600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.352200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.875000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.729800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.891600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.083200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.293730E-02 |
| Normal-VS-Type2 PRCC |
9.027700E-02 |
| Normal-VS-KIRP CIMP |
8.809600E-01 |
| Normal-VS-Unclassified PRCC |
5.302100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.639200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.324100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.713500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.395500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.943800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.699900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.745600E-02 |
| Normal-vs-N1 |
3.036800E-01 |
| Normal-vs-N2 |
9.324000E-01 |
| N0-vs-N1 |
9.373600E-01 |
| N0-vs-N2 |
5.157400E-01 |
| N1-vs-N2 |
6.322800E-01 |
|
|
